Nufarm (NUF) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
19 Nov, 2025Executive summary
Delivered on key profitability and leverage targets, with FY25 revenue up 3% to $3.4b and strong Crop Protection performance; Seed Technologies strategy reprioritized.
Statutory net loss of AUD 165 million, mainly due to AUD 142 million in non-cash material items from Seed Technologies review and performance improvement program.
Net debt reduced by AUD 538 million in the second half, ending at AUD 824 million with leverage at 2.7x.
Underlying EBITDA was AUD 302 million, down 3% year-on-year, but up 10% excluding Emerging platforms.
CEO transition announced, with Rico Christensen appointed as CEO and Managing Director.
Financial highlights
Revenue grew 3% year-on-year to $3,443m; gross profit increased 7% to $900m, with margin up 1 percentage point to 26.1%.
Underlying EBITDA was AUD 302 million; excluding Emerging platforms, underlying EBITDA rose 10% to $355m.
Net financing costs down 6% to AUD 101 million.
Free cash flow was negative AUD 131 million, mainly due to Omega 3 inventory and outflows on interest, tax, and CapEx.
Net debt at year-end was AUD 824 million; leverage ratio 2.7x; gross debt (ex-leases) AUD 1.154 billion.
Outlook and guidance
Expecting strong EBITDA growth in FY2026, assuming normal seasonal and market conditions.
Targeting leverage of 2.0x by end of FY2026, down from 2.7x.
CapEx to be below AUD 200 million in FY2026, with first half CapEx significantly reduced.
Guidance: depreciation/amortization ~AUD 225 million, net interest expense ~AUD 105 million, effective tax rate ~30%.
Positive free cash flow expected, supported by improved working capital and lower Omega 3 cash requirements.
Latest events from Nufarm
- Statutory loss reported, seeds business repositioned, new CEO appointed, all resolutions passed.NUF
AGM 20264 Feb 2026 - EBITDA down 29% and net debt cut 25% as cost discipline and innovation drive FY25 recovery.NUF
H2 202414 Jan 2026 - Shareholders backed all resolutions as the board outlined cost-saving, innovation, and growth plans.NUF
AGM 20259 Jan 2026 - Revenue up 3%, net profit down 39% on omega-3 write-downs; cost and leverage focus.NUF
H1 202520 Nov 2025